Heron Therapeutics
HRTX
HRTX
161 hedge funds and large institutions have $176M invested in Heron Therapeutics in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 51 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 51
24% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 34
27% less capital invested
Capital invested by funds: $242M → $176M (-$66.6M)
Holders
161
Holding in Top 10
3
Calls
$4.61M
Puts
$64K
Top Buyers
| 1 | +$4.71M | |
| 2 | +$1.57M | |
| 3 | +$1.07M | |
| 4 |
CPC
Congress Park Capital
Saratoga Springs,
New York
|
+$730K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$581K |
Top Sellers
| 1 | -$3.17M | |
| 2 | -$2.28M | |
| 3 | -$1.61M | |
| 4 |
Renaissance Technologies
New York
|
-$1.25M |
| 5 |
Squarepoint
New York
|
-$1.22M |